Luca Gasparoli

5PUBLICATIONS
28CO-AUTHORS
Gene and molecular therapyHaematological tumoursChemotherapyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 12, 2026
MCL1 inhibition to enhance the efficacy of MYB targeting in pediatric acute myeloid leukemia.

|Apr 03, 2022
Identification of a c-MYB-directed therapeutic for acute myeloid leukemia.

Katherine Clesham, Vanessa Walf-Vorderwülbecke, Luca Gasparoli

|Jan 17, 2020
Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance.

Eugene Park, Jingyu Chen, Andrew Moore

|May 30, 2019
The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia.

Elena Armenteros-Monterroso, Lu Zhao, Luca Gasparoli

|Apr 06, 2017
The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression.

Andrea Becchetti, Silvia Crescioli, Francesca Zanieri

Pageof 1

Frequent Collaborators

2 joint publications

Owen Williams

1 joint publications

Andrea Becchetti

1 joint publications

Silvia Crescioli

1 joint publications

Serena Pillozzi